Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: AktieTorget
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

WntResearch AB

+ Add to Watchlist

WNT:SS

52.7500 SEK 0.5000 0.94%

As of 12:00:00 ET on 03/05/2015.

Snapshot for WntResearch AB (WNT)

Open: 54.5000 Day's Range: 52.0000 - 60.0000 Volume: 281,629
Previous Close: 53.2500 52wk Range: 14.8000 - 60.0000 1-Yr Rtn: +151.03%

Stock Chart for WNT

No chart data available.
  • WNT:SS 52.7500
  • 1D
  • 1M
  • 1Y
53.2500
Interactive WNT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for WNT

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. OMX -
Earnings Per Share (ttm) -0.4300
Est. EPS -
Est. PEG Ratio -
Market Cap (M SEK) 818.86
Shares Outstanding (M) 15.52
30 Day Average Volume 66,651
Price/Book (mrq) 67.3772
Price/Sale (ttm) 104.2533
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for WNT

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for WNT

WntResearch AB is a cancer research company. The Company develops anti-metastatic therapies based on an understanding of the mechanisms underlying the metastatic process and the evaluation of specific small molecules that can specifically interact with this process.

Peter Buhl JensenChairmanBert JunnoChief Executive Officer
Tommy AnderssonChief Scientific OfficerNils BrunnerScientific Advisor
More Company Profile & Key Executives for WNT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil